Old and New Precipitants in Hepatic Encephalopathy: A New Look at a Field in Continuous Evolution.
Daniele BellafanteStefania GioiaJessica FaccioliOliviero RiggioLorenzo RidolaSilvia NardelliPublished in: Journal of clinical medicine (2023)
Hepatic encephalopathy (HE) is a common complication in patients with advanced liver disease. It is a brain dysfunction characterized by neurological and psychiatric symptoms that significantly affects quality of life, morbidity and mortality of patients. HE has various precipitants that can potentially promote its onset, alone or in combination. Among the historically well-known precipitants, such as infections, gastrointestinal bleeding, dehydration, electrolyte disorders and constipation, recent studies have highlighted the role of malnutrition and portosystemic shunts as new precipitating factors of HE. The identification, management and correction of these factors are fundamental for effective HE treatment, in addition to pharmacological therapy with non-absorbable disaccharides and/or antibiotics.
Keyphrases
- end stage renal disease
- ejection fraction
- early onset
- newly diagnosed
- chronic kidney disease
- peritoneal dialysis
- mental health
- prognostic factors
- oxidative stress
- stem cells
- white matter
- resting state
- mesenchymal stem cells
- brain injury
- multiple sclerosis
- physical activity
- sleep quality
- irritable bowel syndrome
- subarachnoid hemorrhage
- combination therapy
- bioinformatics analysis